Metraipolis › archive › dc_ea204aa74cf4

Antimetastatic effects of MRTX1133 KRAS G12D specific inhibitor in a liver metastatic model of pancreatic ductal adenocarcinoma — Europe PMC PMID:41501279

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41501279
DOI: 10.1038/s41598-[numero omesso]-y
License (as archived): solo-consultazione
Archived: 2026-11-07T00:26:59.286Z
SHA-256 of the archived text: 518010b462ea082974635913b7e23205c11a7797065684cb868aa2471ce4c604
Stable URL of this page: https://metraipolis.com/documento/dc_ea204aa74cf4

How to cite

Antimetastatic effects of MRTX1133 KRAS G12D specific inhibitor in a liver metastatic model of pancreatic ductal adenocarcinoma — Europe PMC PMID:41501279 — Europe PMC (en), https://europepmc.org/article/MED/41501279 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea204aa74cf4 (Metraipolis archive dc_ea204aa74cf4, sha256 518010b462ea082974635913b7e23205c11a7797065684cb868aa2471ce4c604)

BibTeX

@misc{dcea204aa74cf4,
  title = {Antimetastatic effects of MRTX1133 KRAS G12D specific inhibitor in a liver metastatic model of pancreatic ductal adenocarcinoma — Europe PMC PMID:41501279},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41501279},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea204aa74cf4; sha256 518010b462ea082974635913b7e23205c11a7797065684cb868aa2471ce4c604},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41501279. Agents can read the archived copy with the MCP tool read_document.